Delivery Order SPE2DB20D3304-SPE2DB25FW5A1
Award Date
1/5/25
Potential Completion Date
1/27/25
Potential Value
$25K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,604.63, is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty medication. The contract has an ultimate completion date of January 30, 2025 and was awarded on January 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,236.27 firm fixed-price delivery order is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty medication. The contract has an ultimate completion date of January 2, 2025 and was awarded on December 10, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML pharmaceutical products. The $11,827.51 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 26, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,827.51 firm fixed-price contract is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty medication. The $23,655.02 firm-fixed-price contract has a completion date of November 14, 2024. The award is not associated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,236.27, is for the delivery of the medication SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML. The contract has a firm fixed price pricing type and an ultimate completion date of January 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, with a ceiling value of $11,827.51, is for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty pharmaceutical product. The contract is a Firm Fixed Price arrangement with a period of performance through November 7, 2024.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of SKYRIZI 150 MG/ML PENML, a specialty pharmaceutical product. The contract is a firm-fixed price delivery order with a ceiling value of $25,503.51 and an ultimate completion date of August 9, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $11,827.51 firm fixed-price delivery order contract is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty medication, with a completion date of December 10, 2024.
AmerisourceBergen holds two relevant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML pharmaceutical products.
The delivery order has a potential value of $23,655.02 and a performance period through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is part of a larger indefinite...